Group 1 - The core viewpoint of the articles highlights the performance and market position of Weigao Orthopedics, noting its stock price increase and market capitalization [1] - As of June 16, Weigao Orthopedics closed at 25.84 yuan, with a rolling PE ratio of 42.95 times and a total market value of 10.336 billion yuan [1] - The company ranks 86th in the medical device industry, which has an average PE ratio of 49.56 times and a median of 36.18 times [1][2] Group 2 - Weigao Orthopedics has a comprehensive product range covering spinal, trauma, joint, sports medicine, bone repair materials, tissue repair, and orthopedic surgical instruments, making it a leading domestic orthopedic enterprise [1] - The company holds a total of 371 patents, including 86 invention patents and 266 utility model patents [1] - In the first quarter of 2025, Weigao Orthopedics reported an operating income of 290 million yuan, a year-on-year decrease of 16.59%, and a net profit of 51.789 million yuan, a year-on-year increase of 48.37%, with a gross profit margin of 63.68% [1]
威高骨科收盘上涨1.37%,滚动市盈率42.95倍,总市值103.36亿元